Skip to content
Saturday, November 14, 2026
Capital Collective

TikTok Influencers Driving Parallel Trade for Unapproved Slimming Medication

An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of next-day British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of members, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at residence.

Within moments of entering one group, a vendor posted contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Product Information and Costs

Within these communities, messages show black plastic packages with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious medical dangers”.

KI
About the author

Kimberly Irwin

A London-based entrepreneur with over 15 years in fintech and startup consulting.

Capital Collective

Type to search articles.